Professor David Thomas – PrOSPeCT: outsmarting cancer together

Morry Frenkel speaks with Professor David Thomas, founder and CEO of Omico, the Australian Genomic Cancer Medicine Centre and Director of the Centre for Molecular Oncology at the University of New South Wales, about the extremely exciting development in personalised medicine offered by Omico’s Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) program. The free-of-charge program determines the genetic changes (mutations) causing a patient’s cancer and aims to link specific changes with drug trials targeting that mutation. Please consult your medical practitioner and for more information go to www.omico.com.au

Go to https://omny.fm/shows/lchaim-to-life where you will find a full library of past programs and past podcasts.

If you would like to contact us here at L’Chaim our email is lchaim3zzz@gmail.com

For only $16 Please consider becoming a member of the Jewish Group here at 3ZZZ for Seniors only $11 click on https://www.3zzz.com.au/get-involved/membership/. Please ensure that you put “Jewish Group” clearly on your application form.

Am Yisrael Chai   PEACE   L’Chaim